Weight Watchers, which now goes by the designation “WW,” is entering into the telehealth prescription drug space, having entered into a definitive agreement to acquire Sequence for $132 million. 

The subscription telehealth platform offers access to healthcare providers specializing in chronic weight management to connect patients with doctors who can prescribe weight-loss drugs.